Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves’ Disease
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김선화 | - |
dc.contributor.author | 김희영 | - |
dc.contributor.author | 정광윤 | - |
dc.contributor.author | 최동섭 | - |
dc.contributor.author | 김신곤 | - |
dc.date.accessioned | 2021-09-06T06:05:12Z | - |
dc.date.available | 2021-09-06T06:05:12Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2093-596X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/104458 | - |
dc.description.abstract | Radioactive iodine (RAI) therapy has been used as a treatment option for Graves’ disease, and it has been widely accepted to be safe. On the other hand, some evidence suggests that RAI therapy is possibly associated with a small increased risk of thyroid cancer. Herein, we report a rare case of anaplastic thyroid carcinoma (ATC) associated with Graves’ disease, following RAI treatment. A 42-year-old woman had been diagnosed with Graves’ disease and although she was treated with an antithyroid drug, she remained in a hyperthyroid state, which led to two RAI treatments. More than 10 years later, the patient revisited our clinic due to hoarseness, dysphagia, and dyspnea, which had lasted for 2 months. Neck computed tomography suggested thyroid carcinoma and a lymph node biopsy showed metastatic papillary carcinoma. The patient underwent total thyroidectomy and was finally diagnosed as having an ATC. It is not clear if the occurrence of ATC reported here was influenced by the RAI therapy or alternatively,it may only represent the delayed recognition of a rare change in the natural history of Graves’ disease. Nevertheless, this report is worthwhile since it presents a very rare case of ATC that occurred eleven years after the RAI therapy for Graves’ disease. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | 대한내분비학회 | - |
dc.title | Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves’ Disease | - |
dc.title.alternative | Anaplastic Thyroid Carcinoma Following Radioactive Iodine Therapy for Graves’ Disease | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 정광윤 | - |
dc.contributor.affiliatedAuthor | 최동섭 | - |
dc.contributor.affiliatedAuthor | 김신곤 | - |
dc.identifier.bibliographicCitation | Endocrinology and Metabolism, v.28, no.1, pp.61 - 64 | - |
dc.relation.isPartOf | Endocrinology and Metabolism | - |
dc.citation.title | Endocrinology and Metabolism | - |
dc.citation.volume | 28 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 61 | - |
dc.citation.endPage | 64 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001752015 | - |
dc.description.journalClass | 2 | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Thyroid cancer | - |
dc.subject.keywordAuthor | anaplastic | - |
dc.subject.keywordAuthor | Graves disease | - |
dc.subject.keywordAuthor | Radioactive iodine therapy | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.